alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice
 On August 18, 2021, the Department of Justice filed a Complaint and lodged a proposed Consent Decree with the District Court of the Southern District of New York in a lawsuit entitled 
                    *United States*
                     v. 
                    *E.I. DuPont de Nemours and Company, et al.,*
                     Civil Action No. 21-6970. In this action the United States seeks, as provided under the Comprehensive Environmental Response, Compensation and Liability Act, recovery of response costs from four parties regarding the Port Refinery Superfund Site (“Site”) in the Village of Rye Brook, New York. The proposed Consent Decree resolves the United States' claims and requires E.I. DuPont de Nemours and Company, D & D Salvage Corporation, OXY USA Inc., and W.A. Baum Company, Inc., to pay, in aggregate, $1,412,255, in reimbursement of the United States' past response costs regarding the Site. The publication of this notice opens the public comment on the proposed Consent Decree. Comments should be addressed to the Assistant Attorney General, Environment and Natural Resources Division, and should refer to 
                    *United States*
                     v. 
                    *E.I. DuPont de Nemours and Company, et al.,*
                     Civil Action No. 21-6970, D.J. Ref. 90-11-3-1142/7. All comments must be submitted no later than 30 days after the publication date of this notice. Comments may be submitted either by email or by mail: *To submit comments:*
*Send them to:*By email
*pubcomment-ees.enrd@usdoj.gov.*By mail
Assistant Attorney General, U.S. DOJ—ENRD, P.O. Box 7611, Washington, DC 20044-7611.
 During the public comment period, the Consent Decree may be examined and downloaded at this Justice Department website: 
                    *http://www.usdoj.gov/​enrd/​Consent_​Decrees.html.*
                     We will provide a paper copy of the Consent Decree upon written request and payment of reproduction costs. Please email your request and payment to: Consent Decree Library, U.S. DOJ—ENRD, P.O. Box 7611, Washington, DC 20044-7611. Please enclose a check or money order for $5.50 (25 cents per page reproduction cost) payable to the United States Treasury. Henry S. Friedman, Assistant Chief, Environmental Enforcement Section, Environment and Natural Resources Division.


[FR Doc. 2021-18190 Filed 8-23-21; 8:45 am] BILLING CODE 4410-15-P
#### Vidalia Diaz-Mazariegos et al., Appellants, v New York City Health & Hospitals Corporation et al., Respondents.

[947 NYS2d 100]

Order, Supreme Court, New York County (Judy Harris Kluger, J.), entered February 17, 2012, which denied plaintiffs’ motion to deem their notice of claim timely, nunc pro tunc, and granted defendants’ cross motion for dismissal of the complaint on the ground that plaintiffs failed to file a notice of claim within the statutory 90-day period, unanimously affirmed, without costs. Appeal from order, same court and Justice, entered February 17, 2012, which denied plaintiffs’ motion for expedited discovery and a trial preference, unanimously dismissed, without costs, as moot.

*622Plaintiffs allege that defendants committed medical malpractice in failing to earlier diagnose plaintiff Vidalia DiazMazariegos’s breast cancer. The subject claim arose on May 21, 2010, during a post-partum visit at Bellevue Hospital. Plaintiff claims that, during this visit, she made complaints about a lump in her left breast and was told that the condition was related to her pregnancy and milk production. In June 2010, plaintiff returned to Bellevue for an unrelated condition. Plaintiff next sought treatment at Bellevue for her left breast on June 16, 2011, at which time a mass was found. Plaintiff was subsequently diagnosed with breast cancer which had metastasized.

The court properly denied plaintiffs’ motion for leave to extend their time to file a notice of claim against New York City Health & Hospitals Corporation (HHC), as the application was made beyond the time limit for the commencement of an action by plaintiffs against HHC, to wit, one year and 90 days (see General Municipal Law § 50-e [5]; *Croce v City of New York,*69 AD3d 488 [2010]). Plaintiffs have not established that the June 16, 2011 visit was part of a continuous course of treatment for the left breast condition, for purposes of tolling the statute of limitations, as there was no contemplation of further treatment for the condition at the May 2010 visit, no appointments were scheduled for monitoring, and plaintiff made no interim complaints concerning the condition *(see Clayton v Memorial Hosp. for Cancer & Allied Diseases,*58 AD3d 548, 549 [2009]; *cf. Oksman v City of New York,*271 AD2d 213, 215 [2000]).

We have considered appellants’ remaining arguments and find them unavailing. Concur — Tom, J.P., Andrias, Friedman, Moskowitz and Renwick, JJ.
**Exhibit 32**

**CERTIFICATIONS UNDER SECTION 906**

Pursuant to section 906 of the Sarbanes-Oxley Act of2002 (subsections (a) and (b) of section 1350, chapter 63 of title18, United States Code), the undersigned officer of Apogee Technology, Inc.,a Delaware corporation (the “Company”), does hereby certify, to such officer’sknowledge, that:

TheAnnual Report for the year ended December 31, 2004, including the restatedinformation for the year ended December 31, 2003 (the “Form 10-KSB/A,Amendment No. 2”) of the Company fully complies with the requirements of Section 13(a) or15(d) of the Securities Exchange Act of 1934, and the informationcontained in the Form 10-KSB/A, Amendment No. 2 fairlypresents, in all material respects, the financial condition and results ofoperations of the Company.
| Dated: August 19, 2005  | /s/ Herbert M. Stein                                                                 |
|------------------------------|--------------------------------------------------------------------------------------|
|                         | Herbert M. Stein                                                                     |
|                         | Chief Executive Officer and President (principal  executive officer)                 |
| Dated: August 19,  2005 | /s/ Paul J. Murphy                                                                   |
|                         | Paul J. Murphy                                                                       |
|                         | Chief Financial Officer and Vice President of  Finance (principal financial officer) |

 

A signed original of this written statement requiredby Section 906 has been provided to the Company and will be retained bythe Company and furnished to the Securities and Exchange Commission or itsstaff upon request.

----
<TABLE> <S> <C>



<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE  CONTAINS SUMMARY FINANCIAL  INFORMATION  EXTRACTED FROM FINANCIAL
STATEMENTS FOR THE YEAR TO DATE PERIOD ENDED October 3, 1997 AND IS QUALIFIED IN
ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL  STATEMENTS 

Amounts  inapplicable  or not  disclosed as a separate  line on the Statement of
Operations are reported as herein.

 </LEGEND> <CIK>              0001000227
<NAME>                        TB WOOD'S CORPORATION AND SUBSIDIARIES
<MULTIPLIER>                                   1,000
<CURRENCY>                                     US DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              JAN-02-1998
<PERIOD-START>                                 JAN-04-1997
<PERIOD-END>                                   OCT-03-1997
<EXCHANGE-RATE>                                1.000
<CASH>                                             641
<SECURITIES>                                         0
<RECEIVABLES>                                   18,666
<ALLOWANCES>                                       523
<INVENTORY>                                     22,831
<CURRENT-ASSETS>                                42,269
<PP&E>                                          46,190
<DEPRECIATION>                                 (23,095)
<TOTAL-ASSETS>                                  80,701
<CURRENT-LIABILITIES>                           18,232
<BONDS>                                         21,936
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            58
<OTHER-SE>                                      22,516
<TOTAL-LIABILITY-AND-EQUITY>                    80,701
<SALES>                                         93,485
<TOTAL-REVENUES>                                95,444<F1>
<CGS>                                           59,540
<TOTAL-COSTS>                                   21,190
<OTHER-EXPENSES>                                   657
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,297
<INCOME-PRETAX>                                 10,801
<INCOME-TAX>                                     4,320
<INCOME-CONTINUING>                              6,481
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     6,481
<EPS-PRIMARY>                                     1.10
<EPS-DILUTED>                                     1.10


<FN>
<F1>
* Revenues are reported net of credits in the Statement of Operations
</FN>
        

</TABLE>
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

WITOLD KISIEL,

Petitioner

v.

ZBIGNIEW WISZYNSKI,

Respondent :

:

:

:

:

:

:

:

:

:

: No. 623 MAL 2017

Petition for Allowance of Appeal from

the Order of the Superior Court

ORDER

PER CURIAM

AND NOW , this 12th day of March, 2018

, the Petition for Allowance of Appeal is

DENIED

.
Exhibit 31.2


I, Daniel L. Hefner, certify that:

1. I have reviewed this quarterly report on Form 10-KSB of American Commerce Solutions, Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respect tothe period covered by this quarterly report;


3. Based on my knowledge, the financial statements, and other financialinformation included in this quarterly report, fairly present in allmaterial respects the financial condition, results of operations andcash flows of the registrant as of, and for, the periods presented inthis quarterly report;

4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (asdefined in Exchange Act Rules 13a-14 and 15d-14) for the registrantand have:

a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including itsconsolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which thisquarterly report is being prepared;

b) evaluated the effectiveness of the registrant's disclosure controls and procedures as of a date within 90 days prior to thefiling date of this quarterly report (the "Evaluation Date"); and

c) presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based onour evaluation as of the Evaluation Date;

5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant's auditors and theaudit committee of registrant's board of directors (or persons performing the equivalent functions):

a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant'sability to record, process, summarize and report financial dataand have identified for the registrant's auditors any materialweaknesses in internal controls; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant'sinternal controls; and


6. The registrant's other certifying officers and I have indicated in this quarterly report whether or not there were significant changes ininternal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recentevaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.



|                    |                                 |                     
|------------------- | ------------------------------- | --------------------
|                    | **American Commerce Solutions**
|                    |                                 |                     
|Date: July 15, 2004 | By:                             | /s/ Daniel L. Hefner
|                    | Daniel L. Hefner               
|                    | Title: Chief Executive Officer
cara_Ex10_1



		

			Exhibit 10.1

		





		
			CARA THERAPEUTICS, INC.
		

		
			Amended and Restated 
NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
		

		
			Equity:
		

		
			 
		

			
	
			
				 ·
			

			
	
			
			Initial option grant upon joining the board: 38,000 shares




		
			 
		

			
	
			
				 ·
			

			
	
			
			Annual equity awards granted on the date of each annual meeting of stockholders (for directors continuing as directors following the annual meeting):




		
			 
		

		
			For the Chairperson or Lead Independent Director:
		

			
	
			
				 ·
			

			
	
			
			Option: 21,600 shares




			
	
			
				 ·
			

			
	
			
			Restricted stock units: 14,400 shares




		
			 
		

		
			For each other member of the Board:
		

			
	
			
				 ·
			

			
	
			
			Option: 10,800 shares




			
	
			
				 ·
			

			
	
			
			Restricted stock units: 7,200 shares




		
			 
		

		
			The initial option grant will vest over three years in 12 equal quarterly installments, subject to the director’s continued service as a director through each such vesting date.
		

		
			Each annual equity award will vest on the earlier of (1) the one year anniversary of the date of grant and (2) immediately prior to the next annual meeting of stockholders following the date of grant, in each case, subject to the director’s continued service as a director through such date.
		

		
			Cash Comp:
		

		
			 
		

			
	
			
				 ·
			Annual board retainer fee - $40,000




			
	
			
				 ·
			

			
	
			
			Chairperson or Lead Independent Director fee (including annual board retainer fee) - $75,000




			
	
			
				 ·
			

			
	
			
			Audit Committee




			
	
			
				 ·
			

			
	
			
			Chairperson fee (including member fee) - $20,000




			
	
			
				 ·
			

			
	
			
			Member fee - $10,000




			
	
			
				 ·
			

			
	
			
			Compensation Committee




			
	
			
				 ·
			

			
	
			
			Chairperson fee (including member fee) - $15,000




			
	
			
				 ·
			

			
	
			
			Member fee - $7,500




			
	
			
				 ·
			

			
	
			
			Nominating and Corporate Governance Committee




			
	
			
				 ·
			

			
	
			
			Chairperson fee (including member fee) - $10,000




			
	
			
				 ·
			

			
	
			
			Member fee - $5,000




		
			These retainers are payable in arrears in four equal quarterly installments on the last day of each quarter, provided that the amount of such payment will be prorated for any portion of such quarter that the director is not serving on the board of directors or applicable committee. 
		

		
			Reimbursement of Expenses:
		

		
			The Company will reimburse non-employee directors for reasonable travel and out-of-pocket expenses incurred in connection with attending board of director and committee meetings.
#### The People of the State of New York, Respondent, v Jose Ortiz, Appellant.

Appeal by defendant, as limited by his motion, from a sentence of the Supreme Court, Kings County (Coffinas, J.), rendered March 7, 1984, upon his conviction for attempted burglary in the second degree, on his plea of guilty.

Sentence reversed, on the law, and matter remitted to Criminal Term for resentencing.

During the plea proceedings, the court promised to sentence defendant to an indeterminate term of *2Vz*to 5 years’ imprisonment in exchange for his guilty plea to the crime of attempted burglary in the second degree. The court repeated the terms of the promise at the outset of the sentence proceedings. When it came time to impose sentence, however, the court inexplicably sentenced defendant to a lesser term of 2 to 4 years’ imprisonment. It is apparent from the record that the court may have misspoken in rendering this lesser sentence and that it may have actually intended to impose the agreed-upon sentence of 2 *Vz*to 5 years. This conclusion is borne out by the fact that both the order of commitment and an amended order of commitment state that the sentence is a term of imprisonment of *2Vz*to 5 years. In view of this discrepancy we cannot determine what sentence the court intended to impose and therefore defendant’s sentence must be reversed and the matter remitted to Criminal Term for resentencing *(People v Wright,*56 NY2d 613; *People v Minaya,*54 NY2d 360, *cert denied*455 US 1024; *People v Aponte,*110 AD2d 901).

We would also note—although the issue is not formally presented upon this limited appeal from the sentence—that in accepting defendant’s plea, the clerk of the court apparently misspoke as he asked if defendant was pleading guilty to attempted burglary in the third degree rather than attempted burglary in the second degree, as per the plea agreement. Again, the minutes and the orders of commitment otherwise reflect that defendant was convicted of attempted burglary in the second degree *(see, People v Minaya, supra).*

We have examined the other contentions raised both by defendant *pro se*and by his counsel and find them to be without merit *(see, People v Kazepis,*101 AD2d 816; *People v Kepple,*98 AD2d 783). Mollen, P. J., Lazer, Gibbons and Brown, JJ., concur.
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Boston, Massachusetts
 close




            Search small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Northeast Area Boston, Massachusetts People & Locations







Kathi R Wilhelm
                        Boston, Massachusetts

                        




                        
                        Program Analyst
                        Phone: (617) 556-3312
                        
                        
                        Fax: (617) 556-3299(Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Beltsville Agricultural Research Center: Beltsville, MD
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    Careers


        


                    USDA Civil Rights Policy StatementSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home People & Locations







Ramona  Moyer
                        Research Support Services

                        




                        
                        Program Support Assistant (Office Automation)
                        Phone: ((30) 1) -5049
                        
                        
                        Fax: (Employee information on this page comes from the REE Directory. Please contact your front office staff to update the REE Directory.)


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov